Vascepa, a prescription omega-3 fatty acid, is effective in reducing heart disease risk. The medication reduces inflammation and has helped reduce major adverse cardiovascular events by 25% in patients with high triglycerides and established cardiovascular disease, according to the REDUCE-IT trial. Other studies also found Vascepa reduced the risk of cardiovascular events by 18%. The average cost of Vascepa is around $250 per month.
10 Best Free Blue Team Tools in 2025
Companies enhance their cybersecurity through assessments by employing “red teams” for offensive testing and “blue teams” for defense. Blue teams focus on protecting assets, conducting
